Journal of Neurosurgery: Spine Publishes Gornet and Lanman’s Peer-Reviewed Study Documenting Outcome of Two-Level Cervical Disc Replacement with Prestige LP at 24 Months
Beverly Hills (PRWEB) April 07, 2017 -- A new study has been published in the peer-reviewed Journal of Neurosurgery: Spine documenting the favorable outcomes at the two-year postoperative mark of a two-level cervical disc replacement using a Medtronic Prestige LP device in contrast to that of anterior cervical discectomy and fusion surgery (ACDF) for treatment of degenerative disc disease at two adjacent disc levels.
The study, which is now available to the public, was authored by six prominent spine surgeons, one of which includes one of the world’s leading innovators in spine health and total disc replacement, Dr. Todd H. Lanman, founder of the Beverly Hills-based practice Lanman Spinal Neurosurgery (http://www.spine.md). The other surgeons include: Matthew F. Gornet, MD, Jeffrey R. McConnell, MD, J. Kenneth Burkus, MD, Randall F. Dryer, MD, and Scott D. Hodges, DO.
Dr. Lanman was the principal investigator of the clinical trial for the titanium-ceramic composite Prestige LP replacement device, leading to its FDA approval later last year.
The published peer-reviewed medical journal article documents the randomized controlled clinical trial that studied 209 investigational patients undergoing a two-level disc replacement in their cervical spine, or cervical arthroplasty, using a Prestige LP, along with 188 control patients undergoing ACDF, all within the period of June 2006 through November 2007.
At the 24-month post-op mark, overall success, measured against a number of criteria, including neck and arm pain scores, revision surgeries, gait abnormality, neurological status, and other factors, was found to be statistically superior for those undergoing a two-level cervical disc replacement (81.4%) to that of those undergoing ACDF (69.4%).
The conclusion documented by the authors of the study was that two-level cervical disc replacement using a Prestige LP cervical disc replacement device had been found at the 24-month postoperative mark to be just as effective and safe as ACDF for treatment of cervical disc degeneration disease at two adjacent disc levels. Anterior Cervical Discectomy and Fusion (ACDF), which originated in the 1950s, has until recently been the standard surgical procedure for those suffering with the disease.
“It’s exciting to see the transformation that disc replacement has made in people’s lives, keeping them with full motion of the spine and relieving their neck and arm pain,” says Lanman.
One- or two-level artificial disc replacement in the cervical spine is approved by most insurance plans.
About Todd H. Lanman, MD.
As a specialist in the advancement of spinal health and surgery, total disc replacement and motion preservation for more than 25 years, Dr. Todd H. Lanman has earned top honors, his patients’ trust and respect, and recently was named one of the Top Doctors in America. He is also the go-to Spinal Neurosurgeon for many of the world’s leading business leaders and biggest stars. A Diplomate of the American Board of Neurological Surgery and a Fellow of the American College of Surgeons, Dr. Lanman earned his M.D. at Chicago’s Northwestern University in 1983 with top honors and went on to complete his residency in Neurological Surgery at University of California at Los Angeles. Since then, Dr. Lanman has led his leading spinal neurosurgery practice, Lanman Spinal Neurosurgery, in the heart of Beverly Hills, which is affiliated with Cedars-Sinai Medical Center’s Institute for Spinal Disorders, UCLA Medical Center and Saint John’s Medical Center.
As a leading innovator in medicine, as well as a media educator and contributor, Lanman has published more than a dozen peer-reviewed articles, as well as book chapters on topics relating to his field, and has presented more than two dozen papers at national and regional medical society meetings. His expertise is often sought out as he is often tapped to be the principal medical investigator on a wide swath of clinical trials for motion preserving surgeries and artificial disc replacement devices. He has also remained an assistant clinical professor at UCLA for the past 20 years. For more information on Dr. Lanman and Lanman Spinal Neurosurgery, visit http://www.spine.md/
Steven Le Vine, grapevine pr + consulting, http://www.theprgrapevine.com, +1 (323) 386-2300 Ext: 1, [email protected]
Share this article